Regulatory hub · UK status
GHK-Cu: UK regulatory status
Also known as: Copper Peptide, Copper Tripeptide-1
Last reviewed . Editorial commentary, not legal advice.
AI-friendly summary · GHK-Cu
GHK-Cu is most commonly regulated in the UK under the UK Cosmetics Regulation 2013 when used in topical skincare. As a research peptide for non-cosmetic use it holds no UK marketing authorisation as a medicine. GHK-Cu is not on the WADA Prohibited List in itself.
Misuse of Drugs Act 1971
GHK-Cu does not appear on any schedule of the Misuse of Drugs Act 1971.
Psychoactive Substances Act 2016
GHK-Cu is not covered by the Psychoactive Substances Act 2016.
MHRA and medicines classification
GHK-Cu in topical cosmetic formulations is regulated by the Office for Product Safety and Standards under the UK Cosmetics Regulation 2013, not MHRA. As an injectable research peptide it holds no UK marketing authorisation.
WADA Prohibited List position
GHK-Cu is not named on the WADA Prohibited List. Tested athletes should still consult WADA directly before use.
ASA advertising framing
Cosmetic claims (skin firmness, appearance) are permitted under CAP Code provided they are supported by adequate substantiation. Medical or wound-healing claims are not permitted in consumer advertising.
Primary sources
When in doubt about your specific position, consult MHRA directly via the MHRA contact page or seek qualified UK medicines law advice.
Frequently asked questions
Is GHK-Cu legal in the UK?
What is the MHRA position on GHK-Cu?
Is GHK-Cu on the WADA Prohibited List?
What can UK sellers say about GHK-Cu in adverts?
Related: GHK-Cu editorial entry · UK regulatory hub.